# ChronosDx

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/chronosdx

- Industry: Healthcare
- Headquarters: London, UK
- Latest round: Seed (Aug 5, 2022)
- Investors on record: 1

## About

Based in London, UK, ChronosDx Ltd. develops bioassay technology that is used in the process of drug development. In August 2022, ChronosDx Ltd raised a specific amount of seed funding from investor SOSV.

The company offers bioassay technology which is useful in drug development as well as enables in vitro diagnostics in healthcare.  Additionally, its platform detects biomarkers such as cell-free DNA, micro RNA, proteins, metabolites, and exosomes. Furthermore, it enables in-line and in vivo monitoring of biomarkers. The firm’s technology facilitates the testing of new drugs, validation of disease biomarkers, and translates biomarker signatures into high-performance tests across the academic group, drug and diagnostic development companies, and CROs.

## Funding rounds

- Seed, Aug 5, 2022 — SOSV

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed